Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes Who Take Daily Insulin
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Rimouski, Boston MA, Quebec, Stony Brook NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
for
Graves' Disease
Location: Hamilton NJ, Lutherville MD, Richmond VA, Hialeah FL,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT07722546
Phase 2, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: New Haven CT, New York NY, Albany NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase 3, Recruiting
Active & Responsive
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Prilenia
Sex: All
Age: 18 - 70+
Code: NCT07322003
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Brewer ME, Scarborough ME, Peabody MA, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies